United States - English - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - moxifloxacin hydrochloride (unii: c53598599t) (moxifloxacin - unii:u188xyd42p) - moxifloxacin 400 mg

United States - English - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - moxifloxacin hydrochloride (unii: c53598599t) (moxifloxacin - unii:u188xyd42p) - moxifloxacin hydrochloride tablets are indicated in adult patients for the treatment of community acquired pneumonia caused by susceptible isolates of streptococcus pneumoniae (including multi-drug resistant streptococcus pneumoniae [mdrsp]), haemophilus influenzae, moraxella catarrhalis, methicillin-susceptible staphylococcus aureus, klebsiella pneumoniae, mycoplasma pneumoniae, or chlamydophila pneumoniae [see clinical studies (14.3) ]. mdrsp isolates are isolates resistant to two or more of the following antibacterial drugs: penicillin (minimum inhibitory concentrations [mic] ≥ 2 mcg/ml), 2nd generation cephalosporins (for example, cefuroxime), macrolides, tetracyclines, and trimethoprim/sulfamethoxazole. moxifloxacin hydrochloride tablets are indicated in adult patients for the treatment of uncomplicated skin and skin structure infections caused by susceptible isolates of methicillin-susceptible staphylococcus aureus or streptococcus pyogenes [see clinical studies (14.4) ].  moxifloxacin hydrochloride

Ireland - English - HPRA (Health Products Regulatory Authority)

monsanto plc - lomefloxacin hydrochloride - tablets - 400 milligram

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - ciprofloxacin hydrochloride 291.79mg equivalent to ciprofloxacin 250 mg;   - film coated tablet - 250 mg - active: ciprofloxacin hydrochloride 291.79mg equivalent to ciprofloxacin 250 mg   excipient: colloidal silicon dioxide magnesium stearate maize starch microcrystalline cellulose opadry white oy-s-58910 purified talc purified water   sodium starch glycolate

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - ciprofloxacin hydrochloride 583.59mg equivalent to ciprofloxacin 500 mg;   - film coated tablet - 500 mg - active: ciprofloxacin hydrochloride 583.59mg equivalent to ciprofloxacin 500 mg   excipient: colloidal silicon dioxide magnesium stearate maize starch microcrystalline cellulose opadry white oy-s-58910 purified talc purified water   sodium starch glycolate

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - ciprofloxacin hydrochloride 875.39mg equivalent to ciprofloxacin 750 mg;   - film coated tablet - 750 mg - active: ciprofloxacin hydrochloride 875.39mg equivalent to ciprofloxacin 750 mg   excipient: colloidal silicon dioxide magnesium stearate maize starch microcrystalline cellulose opadry white oy-s-58910 purified talc purified water   sodium starch glycolate

Bahrain - English - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

jaffar pharmacy - lomefloxacine - tablet - 400

Singapore - English - HSA (Health Sciences Authority)

zyfas pharma pte ltd - lomefloxacin hcl eqv lomefloxacin - tablet, film coated - 400 mg - lomefloxacin hcl eqv lomefloxacin 400 mg

Bahrain - English - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

yousif mahmood hussain & bahrain pharmacy co - lomefloxacin - eye drops - 0.3

Bangladesh - English - DGDA (Directorate General of Drug Administration)

advanced chemical industries limited - lomefloxacin - tablet - 400 mg